News
2019
company
year
domain
Seres Therapeutics Appoints Stephen Berenson to its Board of Directors
Seres Therapeutics 08.06.2019
Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota Transplantationse
Seres Therapeutics 06.19.2019